Hanna Senko
Medical Scientist
Hanna Senko é investigadora na laboratório Grupo de Investigação Cardiovascular, liderado por Mafalda Bourbon, onde trabalha no âmbito da Bolsa de Investigação “Personalizing diagnosis and treatment for Familial Hypercholesterolemia patients”, e anteriormente atuou como clínica e colaboradora científica no National Scientific Center ‘Institute of Cardiology and Regenerative Medicine’ Named After Academician Mykola Strazhesko.
Concluiu o Mestrado em Medicina Geral na Ukrainian Medical Stomatological Academy (2013–2019) e o Mestrado em Gestão e Administração em Saúde na Sume State University (2019–2021).
No Instituto Strazhesko, participou em atividades clínicas e de investigação, focando-se em eletrofisiologia, arritmias e distúrbios de condução cardíaca, e contribuiu para a elaboração de recomendações metodológicas sobre taquicardias complexas e estudos de aspectos eletrofisiológicos das doenças cardíacas.
Atualmente, na sua posição no laboratório Mafalda Bourbon, continua a desenvolver pesquisas científicas centradas nos aspectos genéticos das dislipidemias, com especial ênfase na Hipercolesterolemia Familiar, realizando estudos funcionais e análises de variantes genéticas em pacientes.
--
Hanna Senko is a researcher at the Cardiovascular Research Group laboratory, led by Mafalda Bourbon, where she works under the research grant “Personalizing diagnosis and treatment for Familial Hypercholesterolemia patients.” She previously served as a clinician and scientific collaborator at the National Scientific Center “Institute of Cardiology and Regenerative Medicine” named after Academician Mykola Strazhesko.
She completed her Master’s degree in General Medicine at the Ukrainian Medical Stomatological Academy (2013–2019) and her Master’s degree in Health Management and Administration at Sumy State University (2019–2021).
At the Strazhesko Institute, she participated in clinical and research activities focusing on electrophysiology, arrhythmias, and cardiac conduction disorders, and contributed to the development of methodological recommendations on complex tachycardias and studies on the electrophysiological aspects of heart diseases.
Currently, in her position at the Mafalda Bourbon laboratory, she continues to conduct scientific research centered on the genetic aspects of dyslipidemias, with a special emphasis on Familial Hypercholesterolemia, performing functional studies and analyses of genetic variants in patients.
Concluiu o Mestrado em Medicina Geral na Ukrainian Medical Stomatological Academy (2013–2019) e o Mestrado em Gestão e Administração em Saúde na Sume State University (2019–2021).
No Instituto Strazhesko, participou em atividades clínicas e de investigação, focando-se em eletrofisiologia, arritmias e distúrbios de condução cardíaca, e contribuiu para a elaboração de recomendações metodológicas sobre taquicardias complexas e estudos de aspectos eletrofisiológicos das doenças cardíacas.
Atualmente, na sua posição no laboratório Mafalda Bourbon, continua a desenvolver pesquisas científicas centradas nos aspectos genéticos das dislipidemias, com especial ênfase na Hipercolesterolemia Familiar, realizando estudos funcionais e análises de variantes genéticas em pacientes.
--
Hanna Senko is a researcher at the Cardiovascular Research Group laboratory, led by Mafalda Bourbon, where she works under the research grant “Personalizing diagnosis and treatment for Familial Hypercholesterolemia patients.” She previously served as a clinician and scientific collaborator at the National Scientific Center “Institute of Cardiology and Regenerative Medicine” named after Academician Mykola Strazhesko.
She completed her Master’s degree in General Medicine at the Ukrainian Medical Stomatological Academy (2013–2019) and her Master’s degree in Health Management and Administration at Sumy State University (2019–2021).
At the Strazhesko Institute, she participated in clinical and research activities focusing on electrophysiology, arrhythmias, and cardiac conduction disorders, and contributed to the development of methodological recommendations on complex tachycardias and studies on the electrophysiological aspects of heart diseases.
Currently, in her position at the Mafalda Bourbon laboratory, she continues to conduct scientific research centered on the genetic aspects of dyslipidemias, with a special emphasis on Familial Hypercholesterolemia, performing functional studies and analyses of genetic variants in patients.